Alpha 2.0
Login Register
» Articles » PMID: 14657229

Chemotherapy or Combined Modality Treatment: the Optimal Treatment for Hodgkin's Disease

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2003 Dec 6
PMID 14657229
Citations 2
Authors
Volker Diehl
Affiliations
Soon will be listed here.
Citing Articles

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).

Gordon L, Hong F, Fisher R, Bartlett N, Connors J, Gascoyne R J Clin Oncol. 2012; 31(6):684-91.

PMID: 23182987 PMC: 3574266. DOI: 10.1200/JCO.2012.43.4803.

The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.

Nakashima M, Ishii Y, Watanabe M, Togano T, Umezawa K, Higashihara M Cancer Sci. 2010; 101(11):2490-6.

PMID: 20735433 PMC: 11159044. DOI: 10.1111/j.1349-7006.2010.01693.x.